Search research articles
Contact Us
Filters
Showing results (81-90 of 93) with videos related to
Page
of 10
Sort By:
International Journal of Cancer
|
March 21, 2019
A prospective study of tea drinking temperature and risk of esophageal squamous cell carcinoma
Farhad Islami, Hossein Poustchi, Akram Pourshams, et al.
Ebiomedicine
|
May 26, 2023
Evaluation of pre-diagnostic blood protein measurements for predicting survival after lung cancer diagnosis
Xiaoshuang Feng, David C Muller, Hana Zahed, et al.
Cancer Epidemiology
|
May 25, 2023
Regional disparities in cancer survival in Iran: Insight from a National Surveillance of Cancer Survival in Iran (IRANCANSURV)
Saeed Nemati, Elnaz Saeedi, Fereshte Lotfi, et al.
Environmental Health Perspectives
|
July 2, 2020
Household Fuel Use and the Risk of Gastrointestinal Cancers: The Golestan Cohort Study
Mahdi Sheikh, Hossein Poustchi, Akram Pourshams, et al.
The Lancet. Global Health
|
May 1, 2020
Opium use and subsequent incidence of cancer: results from the Golestan Cohort Study
Mahdi Sheikh, Ramin Shakeri, Hossein Poustchi, et al.
American Journal of Epidemiology
|
November 18, 2017
Prospective Epidemiological Research Studies in Iran (the PERSIAN Cohort Study): Rationale, Objectives, and Design
Hossein Poustchi, Sareh Eghtesad, Farin Kamangar, et al.
Scientific Reports
|
March 10, 2026
Estimating opium use prevalence at the national and provincial levels in Iran: a modelling study
Saeed Nemati, Mehdi Hatami Goloujeh, Hossein Poustchi, et al.
Ebiomedicine
|
February 22, 2020
Urinary TERT promoter mutations are detectable up to 10 years prior to clinical diagnosis of bladder cancer: Evidence from the Golestan Cohort Study
Md Ismail Hosen, Mahdi Sheikh, Maria Zvereva, et al.
Eclinicalmedicine
|
December 8, 2025
Regular use of pharmaceutical opioids and subsequent risk of cancer: a prospective cohort study and Mendelian randomization analysis
Mahdi Sheikh, Allison Domingues, Karine Alcala, et al.
JAMA
|
May 18, 2026
Biomarker-Based Eligibility for Lung Cancer Screening: Validation of the Protein-Based INTEGRAL-Risk Model
Hana Zahed, Xiaoshuang Feng, Karine Alcala, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 93) with videos related to
Sort By:
Page
of 10
International Journal of Cancer
|
March 21, 2019
A prospective study of tea drinking temperature and risk of esophageal squamous cell carcinoma
Farhad Islami, Hossein Poustchi, Akram Pourshams, et al.
Ebiomedicine
|
May 26, 2023
Evaluation of pre-diagnostic blood protein measurements for predicting survival after lung cancer diagnosis
Xiaoshuang Feng, David C Muller, Hana Zahed, et al.
Cancer Epidemiology
|
May 25, 2023
Regional disparities in cancer survival in Iran: Insight from a National Surveillance of Cancer Survival in Iran (IRANCANSURV)
Saeed Nemati, Elnaz Saeedi, Fereshte Lotfi, et al.
Environmental Health Perspectives
|
July 2, 2020
Household Fuel Use and the Risk of Gastrointestinal Cancers: The Golestan Cohort Study
Mahdi Sheikh, Hossein Poustchi, Akram Pourshams, et al.
The Lancet. Global Health
|
May 1, 2020
Opium use and subsequent incidence of cancer: results from the Golestan Cohort Study
Mahdi Sheikh, Ramin Shakeri, Hossein Poustchi, et al.
American Journal of Epidemiology
|
November 18, 2017
Prospective Epidemiological Research Studies in Iran (the PERSIAN Cohort Study): Rationale, Objectives, and Design
Hossein Poustchi, Sareh Eghtesad, Farin Kamangar, et al.
Scientific Reports
|
March 10, 2026
Estimating opium use prevalence at the national and provincial levels in Iran: a modelling study
Saeed Nemati, Mehdi Hatami Goloujeh, Hossein Poustchi, et al.
Ebiomedicine
|
February 22, 2020
Urinary TERT promoter mutations are detectable up to 10 years prior to clinical diagnosis of bladder cancer: Evidence from the Golestan Cohort Study
Md Ismail Hosen, Mahdi Sheikh, Maria Zvereva, et al.
Eclinicalmedicine
|
December 8, 2025
Regular use of pharmaceutical opioids and subsequent risk of cancer: a prospective cohort study and Mendelian randomization analysis
Mahdi Sheikh, Allison Domingues, Karine Alcala, et al.
JAMA
|
May 18, 2026
Biomarker-Based Eligibility for Lung Cancer Screening: Validation of the Protein-Based INTEGRAL-Risk Model
Hana Zahed, Xiaoshuang Feng, Karine Alcala, et al.
Page
of 10